CAPLIN POINT LABORATORIES LTD SCREENER.

IN

Narration Jun-11 Jun-12 Jun-13 Jun-14 Jun-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Trailing Best Case Worst Case
Sales 80.78 107.21 127.03 173.09 251.77 238.72 401.65 539.84 648.69 863.20 910.72 1,148.64 1,117.70
Expenses 71.58 96.05 104.68 136.90 192.05 174.51 276.40 344.53 416.84 603.13 646.43 763.90 793.34
Operating Profit 9.20 11.16 22.35 36.19 59.72 64.21 125.25 195.31 231.85 260.07 264.29 384.74 324.35
Other Income 2.55 2.51 2.10 3.72 3.02 3.66 9.52 12.67 19.03 41.33 43.35 - -
Depreciation 2.32 1.24 1.54 3.54 8.38 7.48 13.30 19.00 23.43 31.62 33.19 33.19 33.19
Interest 1.20 1.26 0.77 0.68 0.97 0.34 0.52 0.61 0.58 0.32 0.82 0.82 0.82
Profit before tax 8.23 11.17 22.14 35.69 53.39 60.05 120.95 188.37 226.87 269.46 273.63 350.73 290.34
Tax 1.92 3.14 8.12 9.75 12.26 14.28 25.45 43.74 50.32 54.38 54.06 20% 20%
Net profit 6.28 8.01 13.98 25.85 41.04 45.76 95.61 144.79 176.57 215.01 219.30 281.44 232.98
EPS 0.83 1.06 1.85 3.42 5.43 6.05 12.65 19.15 23.36 28.44 28.99 37.21 30.80
Price to earning 5.38 4.87 5.08 12.72 34.29 33.38 30.71 29.74 17.20 9.93 18.86 18.93 18.38
Price 4.47 5.16 9.40 43.49 186.17 202.04 388.35 569.55 401.70 282.40 546.70 704.35 566.05

RATIOS:
Dividend Payout 360.83% 37.70% 27.04% 23.37% 18.42% 19.82% 11.86% 10.44% 9.42% 8.79%
OPM 11.39% 10.41% 17.59% 20.91% 23.72% 26.90% 31.18% 36.18% 35.74% 30.13% 29.02%

TRENDS: 10 YEARS 7 YEARS 5 YEARS 3 YEARS RECENT BEST WORST

Sales Growth 30.11% 31.49% 27.94% 29.05% 33.07% 33.07% 27.94%
OPM 29.58% 31.20% 32.57% 33.50% 29.02% 33.50% 29.02%
Price to Earning 18.38 23.35 23.30 18.93 18.86 18.93 18.38
CAPLIN POINT LABORATORIES LTD SCREENER.IN

Narration Mar-18 Jun-18 Sep-18 Dec-18 Mar-19 Jun-19 Sep-19 Dec-19 Mar-20 Jun-20
Sales 143.41 146.46 155.86 159.03 187.34 192.55 227.20 228.21 215.23 240.08
Expenses 94.70 93.43 100.07 101.28 122.59 125.17 156.08 160.45 161.42 168.48
Operating Profit 48.71 53.03 55.79 57.75 64.75 67.38 71.12 67.76 53.81 71.60
Other Income 2.90 1.61 7.01 7.74 2.67 4.47 6.89 10.34 19.63 6.49
Depreciation 6.18 5.45 5.58 5.67 6.72 7.39 7.41 8.42 8.40 8.96
Interest 0.01 0.01 0.02 0.01 0.01 0.01 0.08 0.06 0.17 0.51
Profit before tax 45.42 49.18 57.20 59.81 60.69 64.45 70.52 69.62 64.87 68.62
Tax 10.13 11.78 13.71 14.01 10.84 14.39 13.25 10.73 16.01 14.07
Net profit 35.36 37.43 43.51 45.83 49.81 50.23 57.32 58.56 48.89 54.53

OPM 34% 36% 36% 36% 35% 35% 31% 30% 25% 30%
CAPLIN POINT LABORATORIES LTD SCREENER.IN

Narration Jun-11 Jun-12 Jun-13 Jun-14 Jun-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20
Equity Share Capital 15.11 15.11 15.11 15.11 15.11 15.11 15.12 15.12 15.13 15.13
Reserves 13.97 18.47 28.03 46.63 78.08 113.03 209.65 348.71 513.99 932.79 918.82
Borrowings 9.74 6.88 4.70 3.33 2.08 2.00 0.73 0.53 0.54 38.61
Other Liabilities 32.55 66.66 87.07 114.85 133.56 137.00 132.88 136.09 212.86 139.23
Total 71.37 107.12 134.91 179.92 228.83 267.14 358.38 500.45 742.52 1,125.76
0.08 -3.44
Net Block 24.95 27.54 32.71 102.24 113.13 144.23 151.83 169.48 226.84 272.50
Capital Work in Progress 0.17 12.79 51.48 24.96 30.63 0.23 3.42 15.29 9.70 20.12
Investments 1.15 1.14 1.19 0.44 0.45 0.44 17.44 46.67 69.96 60.79 59.64
Other Assets 45.10 65.65 49.53 52.28 84.62 122.24 185.69 269.01 436.02 772.35
Total 71.37 107.12 134.91 179.92 228.83 267.14 358.38 500.45 742.52 1,125.76

Working Capital 12.55 -1.01 -37.54 -62.57 -48.94 -14.76 52.81 132.92 223.16 633.12
Debtors 8.33 7.28 0.86 0.09 5.66 7.95 33.02 125.88 159.81 228.96
Inventory 5.50 6.38 10.42 9.79 13.66 18.81 22.29 28.46 37.45 238.23

Debtor Days 37.64 24.79 2.47 0.19 8.21 12.16 30.01 85.11 89.92 96.81
Inventory Turnover 14.69 16.80 12.19 17.68 18.43 12.69 18.02 18.97 17.32 3.62

Return on Equity 22% 24% 32% 42% 44% 36% 43% 40% 33% 23%
Return on Capital Emp 31% 52% 64% 68% 54% 68% 64% 51% 36%
CAPLIN POINT LABORATORIES LTD SCREENER.IN

Narration Jun-11 Jun-12 Jun-13 Jun-14 Jun-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20
Cash from Operating Activity 14.25 27.92 31.95 59.83 49.88 42.40 67.61 66.49 83.42 44.68
Cash from Investing Activity -6.90 -16.44 -45.44 -43.89 -22.66 -5.72 -36.11 -69.03 -99.73 -54.50
Cash from Financing Activity -0.37 -1.30 -1.47 -5.96 -8.67 -13.95 -6.74 -11.60 89.79 79.77
Net Cash Flow 6.98 10.18 -14.96 9.98 18.55 22.73 24.76 -14.14 73.48 69.94
Report Date Mar-10 Mar-11 Mar-12 Mar-13 Mar-14 Mar-15
Sales 80.78 107.21 127.03 173.09 251.77 238.72
Net profit 6.28 8.01 13.98 25.85 41.04 45.76
Depreciation 2.32 1.24 1.54 3.54 8.38 7.48
Dividend Amount 22.66 3.02 3.78 6.04 7.56 9.07
Net Block 24.95 27.54 32.71 102.24 113.13 144.23
NFAT 4.08 4.22 2.57 2.34 1.86
NPM 8% 7% 11% 15% 16% 19%
DPR 361% 38% 27% 23% 18% 20%
DEP(DEP as % of NFA) 9% 5% 5% 3% 7% 5%
3 yr nfat 3.62 3.04 2.25
3 yr npm 11% 14% 17%
3 yr dpr 29% 23% 21%
3 yr dep 4% 5% 5%
ssgr 24% 28% 25%
inventory turnover(higher is better) 18 15 17 21 15
receivable days(lower is better) 27 12 1 4 10
asset turnover (higher is better) 4.1 4.2 2.6 2.3 1.9
working capital cycle 47 36 22 21 35
CWIP 0 13 51 25 31 0
CPAT
CFO 14 28 32 60 50 42
CAPEX 16 45 47 25 8
FCF 11 -13 13 25 34
CFI -6.9 -16.44 -45.44 -43.89 -22.66 -5.72
CFF -0.37 -1.3 -1.47 -5.96 -8.67 -13.95
CFI+CFF
debt 10 7 5 3 2 2
Debt taken(paid) -3 -2 -1 -1 0
dividend paid
FCF/CAPEX
debt/equity 0.3 0.2 0.1 0.1 0.0 0.0

Mar-10 Mar-11 Mar-12 Mar-13 Mar-14 Mar-15

reserves 4.5 9.56 18.6 31.45 34.95
inventory sold -0.88 -4.04 0.63 -3.87 -5.15
fixed asset sold (2.59) (5.17) (69.53) (10.89) (31.10)
STL 4.4 7.38 11.01 12.17 10.9 23.54
LTL 0 0 1.25 3.67 3.44 2.65
PAYABLES 25 43 86 64 61 48
STL GIVEN 2.98 3.63 1.16 -1.27 12.64
LTL SOLD 0 -1.25 -2.42 0.23 0.79

TTL FUND RECEIVED 1.03 (0.90) (52.72) 16.92 (0.51)

LTD+STD PAID 2.86 2.18 1.37 1.25 0.08
CASH INCREASE 10.18 -14.96 9.98 18.55 22.73
CREDIT TO CUSTOMERS -1.05 -6.42 -0.77 5.57 2.29
STL GIVEN 2.98 3.63 1.16 -1.27 12.64
TRADE PAYABLES PAID -18 -43 22 3 13

TTL FUND OUTFLOW -3.03 -58.57 33.74 27.1 50.74

Mar-16 Mar-17 Mar-18 Mar-19 GROWTH RATE GROWTH RATE 3 GROWTH RATE 5 YRS
401.65 539.84 648.69 863.20 30% 29% 28%
95.61 144.79 176.57 215.01 48% 31% 39%
13.30 19.00 23.43 31.62
11.34 15.12 16.64 18.91
151.83 169.48 226.84 272.50
2.71 3.36 3.27 3.46
24% 27% 27% 25%
12% 10% 9% 9%
9% 11% 10% 12%
2.30 2.64 3.12 3.36
20% 23% 26% 26%
17% 14% 11% 10%
7% 8% 10% 11%
31% 44% 62% 69%
20 21 20 6
19 54 80 82
2.7 3.4 3.3 3.5
37 71 99 140
3 15 10 20
773
68 66 83 45 488
24 49 75 88 377
44 18 8 -43 97
-36.11 -69.03 -99.73 -54.5 -400
-6.74 -11.6 89.79 79.77 120
-281
1 1 1 39
-1 0 0 38 29
114
0.26
0.0 0.0 0.0 0.0

Mar-16 Mar-17 Mar-18 Mar-19

96.62 139.06 165.28 418.8
-3.48 -6.17 -8.99 -200.78
(7.60) (17.65) (57.36) (45.66)
19.28 20.65 21.42 18.04
3.05 1.78 4.61 2.91
52 49 76 86
-4.26 1.37 0.77 -3.38
-0.4 1.27 -2.83 1.7

85.14 116.51 96.10 174.06 435.63

 1.27 0.2 -0.01 -38.07 -28.87
24.97 -13.79 73.71 70.44 201.81
25.07 92.86 33.93 69.15 220.63
-4.26 1.37 0.77 -3.38 13.64
-4 3 -27 -10 -61
0
43.05 83.64 81.4 88.14 346.21
How to use it?
You can customize this workbook as you want.
You can add custom formating, add conditional formating, add your own formulas… do ANYTHING.
Please don't edit the "Data Sheet" only.

After customization, you can upload this back on Screener.

Upload on: https://www.screener.in/excel/

Download your customized workbooks now onwards.

Now whenever you will "Export to excel" from Screener, it will export your customized file.

TESTING:
This is a testing feature currently.
You can report any formula errors on the worksheet at: screener.feedback@dalal-street.in
s… do ANYTHING.

dalal-street.in
COMPANY NAME CAPLIN POINT LABORATORIES LTD
LATEST VERSION 2.10 PLEAS
CURRENT VERSION 2.10

META
Number of shares 7.56
Face Value 2.00
Current Price 546.70
Market Capitalization 4,135.39

PROFIT & LOSS

Report Date Jun-11 Jun-12 Jun-13 Jun-14
Sales 80.78 107.21 127.03 173.09
Raw Material Cost 61.37 77.21 85.69 103.54
Change in Inventory 0.49 -0.15 1.24 0.96
Power and Fuel 0.68 0.84 1.12 3.07
Other Mfr. Exp 1.57 1.63 2.41 5.34
Employee Cost 4.19 6.35 7.81 12.76
Selling and admin 3.09 3.91 5.55 8.67
Other Expenses 1.17 5.96 3.34 4.48
Other Income 2.55 2.51 2.10 3.72
Depreciation 2.32 1.24 1.54 3.54
Interest 1.20 1.26 0.77 0.68
Profit before tax 8.23 11.17 22.14 35.69
Tax 1.92 3.14 8.12 9.75
Net profit 6.28 8.01 13.98 25.85
Dividend Amount 22.66 3.02 3.78 6.04

Quarters
Report Date Mar-18 Jun-18 Sep-18 Dec-18
Sales 143.41 146.46 155.86 159.03
Expenses 94.70 93.43 100.07 101.28
Other Income 2.90 1.61 7.01 7.74
Depreciation 6.18 5.45 5.58 5.67
Interest 0.01 0.01 0.02 0.01
Profit before tax 45.42 49.18 57.20 59.81
Tax 10.13 11.78 13.71 14.01
Net profit 35.36 37.43 43.51 45.83
Operating Profit 48.71 53.03 55.79 57.75

BALANCE SHEET
Report Date Jun-11 Jun-12 Jun-13 Jun-14
Equity Share Capital 15.11 15.11 15.11 15.11
Reserves 13.97 18.47 28.03 46.63
Borrowings 9.74 6.88 4.70 3.33
Other Liabilities 32.55 66.66 87.07 114.85
Total 71.37 107.12 134.91 179.92
Net Block 24.95 27.54 32.71 102.24
Capital Work in Progress 0.17 12.79 51.48 24.96
Investments 1.15 1.14 1.19 0.44
Other Assets 45.10 65.65 49.53 52.28
Total 71.37 107.12 134.91 179.92
Receivables 8.33 7.28 0.86 0.09
Inventory 5.50 6.38 10.42 9.79
Cash & Bank 21.62 31.80 16.84 26.82
No. of Equity Shares 15,110,000.00 15,110,000.00 15,110,000.00 15,110,000.00
New Bonus Shares
Face value 10.00 10.00 10.00 10.00

CASH FLOW:
Report Date Jun-11 Jun-12 Jun-13 Jun-14
Cash from Operating Activity 14.25 27.92 31.95 59.83
Cash from Investing Activity -6.90 -16.44 -45.44 -43.89
Cash from Financing Activity -0.37 -1.30 -1.47 -5.96
Net Cash Flow 6.98 10.18 -14.96 9.98

PRICE: 4.47 5.16 9.40 43.49

DERIVED:
Adjusted Equity Shares in Cr 7.56 7.56 7.56 7.56
 PLEASE DO NOT MAKE ANY CHANGES TO THIS SHEET

Jun-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20

251.77 238.72 401.65 539.84 648.69 863.20
136.42 121.84 184.78 240.57 298.85 608.26
0.80 0.68 -0.15 2.39 10.07 195.10
8.61 7.56 9.91 10.98 13.76
10.16 9.89 17.31 15.38 16.22
18.78 18.47 30.81 39.14 47.11 67.76
14.41 12.60 32.04 38.39 48.63
4.47 4.83 1.40 2.46 2.34 122.21
3.02 3.66 9.52 12.67 19.03 41.33
8.38 7.48 13.30 19.00 23.43 31.62
0.97 0.34 0.52 0.61 0.58 0.32
53.39 60.05 120.95 188.37 226.87 269.46
12.26 14.28 25.45 43.74 50.32 54.38
41.04 45.76 95.61 144.79 176.57 215.01
7.56 9.07 11.34 15.12 16.64 18.91

Mar-19 Jun-19 Sep-19 Dec-19 Mar-20 Jun-20

187.34 192.55 227.20 228.21 215.23 240.08
122.59 125.17 156.08 160.45 161.42 168.48
2.67 4.47 6.89 10.34 19.63 6.49
6.72 7.39 7.41 8.42 8.40 8.96
0.01 0.01 0.08 0.06 0.17 0.51
60.69 64.45 70.52 69.62 64.87 68.62
10.84 14.39 13.25 10.73 16.01 14.07
 49.81 50.23 57.32 58.56 48.89 54.53
64.75 67.38 71.12 67.76 53.81 71.60

Jun-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20

15.11 15.11 15.12 15.12 15.13 15.13
78.08 113.03 209.65 348.71 513.99 932.79
2.08 2.00 0.73 0.53 0.54 38.61
133.56 137.00 132.88 136.09 212.86 139.23
228.83 267.14 358.38 500.45 742.52 1,125.76
113.13 144.23 151.83 169.48 226.84 272.50
30.63 0.23 3.42 15.29 9.70 20.12
0.45 0.44 17.44 46.67 69.96 60.79
84.62 122.24 185.69 269.01 436.02 772.35
228.83 267.14 358.38 500.45 742.52 1,125.76
5.66 7.95 33.02 125.88 159.81 228.96
13.66 18.81 22.29 28.46 37.45 238.23
45.37 68.10 93.07 79.28 152.99 223.43
15,110,000.00 15,110,000.00 75,576,750.00 75,603,500.00 75,630,250.00
-63.45
10.00 10.00 2.00 2.00 2.00 2.00

Jun-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20

49.88 42.40 67.61 66.49 83.42 44.68
-22.66 -5.72 -36.11 -69.03 -99.73 -54.50
-8.67 -13.95 -6.74 -11.60 89.79 79.77
18.55 22.73 24.76 -14.14 73.48 69.94

186.17 202.04 388.35 569.55 401.70 282.40

7.56 7.56 7.56 7.56 7.56 7.56